文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性低氧性呼吸衰竭:较低与较高氧合目标对比

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure.
PubMed 文献 · N Engl J Med · 2021-01-20
一句话结论ICU急性低氧性呼吸衰竭成人中,较低Pao2目标(60 mmHg)与较高目标(90 mmHg)90天死亡率无差异。

HOT-ICU多中心RCT纳入2928例近期入ICU(≤12小时)、开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50的成人急性低氧性呼吸衰竭患者,随机接受Pao2目标60 mmHg或90 mmHg氧疗,最长90天。90天死亡率低氧组42.9%、高氧组42.4%(校正RR 1.02,95%CI 0.94–1.11,P=0.64)。无生命支持存活天数、出院后存活天数及新发休克、心肌缺血、缺血性卒中、肠缺血比例均无显著差异。提示较低氧合目标未降低死亡率。

要点

  • 入组条件:ICU成人、随机化前≤12小时入ICU,开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50。
  • 随机目标:Pao2 60 mmHg(低氧组) vs 90 mmHg(高氧组),氧疗最长90天。
  • 主要终点90天死亡:低氧组42.9%(618/1441) vs 高氧组42.4%(613/1447),校正RR 1.02(95%CI 0.94–1.11),P=0.64。
  • 无生命支持存活天数、出院后存活天数两组无显著差异。
  • 新发休克、心肌缺血、缺血性卒中、肠缺血比例两组相似(P=0.24)。

适用人群与场景

  • 成人急性低氧性呼吸衰竭患者,近期入ICU(随机化前≤12小时),且开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50。

诊断标准与关键阈值

  • 急性低氧性呼吸衰竭:ICU成人,随机化前≤12小时入ICU,开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50。
  • 氧合目标分组:低氧组Pao2目标60 mmHg;高氧组Pao2目标90 mmHg。

处置流程与药物剂量

  • 第一步:筛选近期入ICU(≤12小时)、开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50的成人急性低氧性呼吸衰竭患者。
  • 第二步:随机分配至Pao2目标60 mmHg(低氧组)或90 mmHg(高氧组)进行氧疗,最长90天。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:多中心随机对照试验(HOT-ICU,NCT03174002),样本量2928例。
  • 人群:成人急性低氧性呼吸衰竭,随机化前≤12小时入ICU,开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50。
  • 干预与对照:Pao2目标60 mmHg(低氧组,n=1441) vs 90 mmHg(高氧组,n=1447),氧疗最长90天。
  • 主要终点:90天死亡,低氧组42.9%(618/1441) vs 高氧组42.4%(613/1447),校正RR 1.02(95%CI 0.94–1.11),P=0.64。
  • 关键次要终点:90天无生命支持存活天数、出院后存活天数两组无显著差异。
  • 不良事件:新发休克、心肌缺血、缺血性卒中、肠缺血比例两组相似(P=0.24)。

证据类型、等级与局限

  • 证据类型:多中心随机对照试验(RCT)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:原文未提及;设计本身为多中心RCT,样本量2928例。

对床旁实践的改变

  • 对ICU成人急性低氧性呼吸衰竭(开放系统吸氧≥10 L/min或闭合系统FiO2≥0.50),将Pao2目标设为60 mmHg或90 mmHg在90天死亡率上无差异,不支持为降低死亡率而常规采用较低氧合目标。
  • 原文未提及适用与不适用人群的进一步限定或常见陷阱。

指南或共识出处

  • 原文未提及指南或共识名称;研究由Innovation Fund Denmark等资助,ClinicalTrials.gov注册号NCT03174002。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated with supplemental oxygen, but the benefits and harms of different oxygenation targets are unclear. We hypothesized that using a lower target for partial pressure of arterial oxygen (Pao2) would result in lower mortality than using a higher target.

METHODS: In this multicenter trial, we randomly assigned 2928 adult patients who had recently been admitted to the ICU (≤12 hours before randomization) and who were receiving at least 10 liters of oxygen per minute in an open system or had a fraction of inspired oxygen of at least 0.50 in a closed system to receive oxygen therapy targeting a Pao2 of either 60 mm Hg (lower-oxygenation group) or 90 mm Hg (higher-oxygenation group) for a maximum of 90 days. The primary outcome was death within 90 days.

RESULTS: At 90 days, 618 of 1441 patients (42.9%) in the lower-oxygenation group and 613 of 1447 patients (42.4%) in the higher-oxygenation group had died (adjusted risk ratio, 1.02; 95% confidence interval, 0.94 to 1.11; P = 0.64). At 90 days, there was no significant between-group difference in the percentage of days that patients were alive without life support or in the percentage of days they were alive after hospital discharge. The percentages of patients who had new episodes of shock, myocardial ischemia, ischemic stroke, or intestinal ischemia were similar in the two groups (P = 0.24).

CONCLUSIONS: Among adult patients with acute hypoxemic respiratory failure in the ICU, a lower oxygenation target did not result in lower mortality than a higher target at 90 days. (Funded by the Innovation Fund Denmark and others; HOT-ICU ClinicalTrials.gov number, NCT03174002.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Schjørring OL, Klitgaard TL, Perner A, et al. Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure. N Engl J Med. 2021. PMID: 33471452. doi:10.1056/NEJMoa2032510

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。